Contingency management for cocaine use in methadone maintenance patients: When does abstinence happen?

Psychology of Addictive Behaviors

Volumn 24, Issue 2, 2010, Pages 282-291

  Weinstock, Jeremiah ^a   Rash, Carla J ^a   Petry, Nancy M ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Cocaine abstinence; Contingency management; Discrete time analysis; Methadone maintenance; Treatment response

Indexed keywords

METHADONE; NARCOTIC AGENT;

ANALYSIS; ARTICLE; COCAINE DEPENDENCE; CONTINGENCY MANAGEMENT; CONTROLLED STUDY; DISCRETE TIME ANALYSIS; DISEASE DURATION; DISEASE SEVERITY; DRUG WITHDRAWAL; FEMALE; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; PATIENT MONITORING; PROBABILITY; TREATMENT RESPONSE; URINALYSIS; ADULT; ANALYSIS OF VARIANCE; BEHAVIOR THERAPY; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; METHODOLOGY; OPIATE ADDICTION; RANDOMIZED CONTROLLED TRIAL; SUBSTANCE ABUSE; TREATMENT OUTCOME;

ADULT; ANALYSIS OF VARIANCE; BEHAVIOR THERAPY; CHI-SQUARE DISTRIBUTION; COCAINE-RELATED DISORDERS; FEMALE; HUMANS; MALE; METHADONE; NARCOTICS; OPIOID-RELATED DISORDERS; SUBSTANCE ABUSE DETECTION; TREATMENT OUTCOME;

EID: 77954148990     PISSN: 0893164X     EISSN: None     Source Type: Journal    
DOI: 10.1037/a0017542     Document Type: Article

References (38)

1. Brooner R.K., Kidorf M.S., King V.L., Stoller K.B., Neufeld K. Comparing adaptive stepped care and monetary-based voucher interventions for opioid dependence. Drug and Alcohol Dependence 2007, 88S:S14-S23.
2. Dallery J., Silverman K., Chutuape M., Bigelow G., Stitzer M. Voucher-based reinforcement of opiate plus cocaine abstinence in treatment-resistant methadone patients: Effects of reinforce magnitude. Experimental and Clinical Psychopharmacology 2001, 9:317-325.
3. DeMaria P.A., Sterling R., Weinstein S.P. The effect of stimulant and sedative use on treatment outcome of patients admitted to methadone maintenance treatment. American Journal on Addictions 2000, 9:145-153.
4. Downey K.K., Helmus T.C., Schuster C.R. Treatment of heroin-dependent polydrug abusers with contingency management and buprenorphine maintenance. Experimental and Clinical Psychopharmacology 2000, 8:176-184.
5. Dunteman G.H., Condelli W.S., Fairbank J.A. Predicting cocaine use among methadone patients: Analysis of findings from a national study. Hospital & Community Psychiatry 1992, 43:608-611.
6. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version 1996, American Psychiatric Press, Washington, DC.
7. Griffith J.D., Rowan-Szal G.A., Roark R.R., Simpson D.D. Contingency management in outpatient methadone treatment: A meta-analysis. Drug and Alcohol Dependence 2000, 58:55-66.
8. Henggeler S.W., Chapman J.E., Rowland M.D., Halliday-Boykins C.A., Randall J., Shackelford J., et al. Statewide adoption and initial implementation of contingency management for substance-abusing adolescents. Journal of Consulting and Clinical Psychology 2008, 76:556-567.
9. Kampman K.M., Volpicelli J.R., Mulvaney F., Rukstalis M., Alterman A.I., Pettinati H., et al. Cocaine withdrawal severity and urine toxicology results from treatment entry predict outcome in medication trials for cocaine dependence. Addictive Behaviors 2002, 27:251-260.
10. Katz E.C., Robles-Sotelo E., Correira C.J., Silverman K., Stitzer M.L., Bigelow G. The brief abstinence test: Effects of continued incentive availability on cocaine abstinence. Journal of Consulting and Clinical Psychology 2002, 69:643-654.
11. Kidorf M., Stitzer M.L., Brooner R.M. Characteristics of methadone patients responding to take-home incentives. Behavior Therapy 1994, 25:109-121.
12. Kranzler H.R., Kadden R.M., Babor T.F., Tennen H., Rounsaville B.J. Validity of the SCID in substance abuse patients. Addiction 1996, 91:859-868.
13. Lussier J.P., Heil S.H., Mongeon J.A., Badger G.J., Higgins S.T. A meta-analysis of voucher based reinforcement therapy for substance use disorders. Addiction 2006, 101:192-203.
14. Morral A.R., Belding M.A., Iguchi M.Y. Identifying methadone maintenance clients at risk for poor treatment response: Pretreatment and early progress indicators. Drug and Alcohol Dependence 1999, 55:25-33.
15. Olmstead T.A., Sindelar J.L., Petry N.M. Clinic variation in the cost-effectiveness of contingency management. American Journal on Addiction 2007, 16:457-460.
16. Peirce J.M., Petry N.M., Stitzer M.L., Blaine J., Kolodner K., Li R., et al. Lower-cost incentives increase stimulant abstinence in methadone maintenance community treatment: Results of the National Drug Abuse Treatment Clinical Trials Network Multi-Site Study. Archives of General Psychiatry 2006, 63:201-208.
17. Petry N.M., Alessi S.M., Hanson T., Sierra S. Randomized trial of contingent prizes versus vouchers in cocaine-using methadone patients. Journal of Consulting and Clinical Psychology 2007, 75:983-991.
18. Petry N.M., Alessi S.M., Marx J., Austin M., Tardif M. Vouchers versus prizes: Contingency management treatment of substance abusers in community settings. Journal of Consulting and Clinical Psychology 2005, 73:1005-1014.
19. Petry N.M., Martin B. Low-cost contingency management for treating cocaine- and opioid-abusing methadone patients. Journal of Consulting and Clinical Psychology 2002, 70:398-405.
20. Petry N.M., Martin B., Simcic F. Prize reinforcement contingency management for cocaine dependence: Integration with group therapy in a methadone clinic. Journal of Consulting and Clinical Psychology 2005, 73:354-359.
21. Petry N.M., Peirce J.M., Stitzer M.L., Blaine J., Roll J.M., Cohen A., et al. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs. Archives of General Psychiatry 2005, 62:1148-1156.
22. Petry N.M., Tedford J., Austin M., Nich C., Carroll K.M., Rounsaville B.J. Prize reinforcement contingency management for treatment of cocaine abusers: How low can we go, and with whom?. Addiction 2004, 99:349-360.
23. Piotrowski N.A., Tusel D.J., Sees K.L., Reilly P.M., Banys P., Meek P., et al. Contingency contracting with monetary reinforcers for abstinence from multiple drugs in a methadone program. Experimental and Clinical Psychopharmacology 1999, 7:399-411.
24. Plebani J.G., Kampman K.M., Lynch K.G. Early abstinence in cocaine pharmacotherapy trials predicts successful treatment outcomes. Journal of Substance Abuse Treatment 2009, 37:313-317.
25. Poling J., Kosten T.R., Sofuoglu M. Treatment outcome predictors for cocaine dependence. American Journal of Drug and Alcohol Abuse 2007, 33:191-206.
26. Prendergast M., Podus D., Finney J., Greenwell L., Roll J. Contingency management for substance use disorders: A meta-analysis. Addiction 2006, 101:1546-1560.
27. Preston K.L., Silverman K., Higgins S.T., Brooner R.K., Montoay I., Schuster C.R., et al. Cocaine use early in treatment predicts outcome in a behavioral treatment program. Journal of Consulting and Clinical Psychology 1998, 66:691-696.
28. Preston K.L., Umbricht A., Wong C.J., Epstein D.H. Shaping cocaine abstinence by successive approximation. Journal of Consulting and Clinical Psychology 2001, 69:643-654.
29. Silverman K., Chutuape M.A., Bigelow G.E., Stitzer M.L. Voucher-based reinforcement of cocaine abstinence in treatment-resistant methadone patients: Effects of reinforcement magnitude. Psychopharmacology 1999, 146:128-138.
30. Silverman K., Robles E., Mudric T., Bigelow G.E., Stitzer M.L. A randomized trial of long-term reinforcement of cocaine abstinence in methadone maintenance patients who inject drugs. Journal of Consulting and Clinical Psychology 2004, 72:839-854.
31. Singer J.D., Willett J.B. Applied longitudinal data analysis: Modeling change and event occurrence 2003, Oxford University Press, New York.
32. Sofuoglu M., Gonzalez G., Poling J., Kosten T.R. Prediction of treatment outcome by baseline urine cocaine results and self-reported cocaine use for cocaine and opioid dependence. American Journal of Drug and Alcohol Abuse 2003, 29:713-727.
33. Stitzer M., Petry N. Contingency management for treatment of substance abuse. Annual Review of Clinical Psychology 2006, 2:411-434.
34. Stitzer M., Petry N., Peirce J., Kirby K., Killeen T., Roll J., et al. Effectiveness of abstinence-based incentives: Interaction with intake stimulant test results. Journal of Consulting and Clinical Psychology 2007, 75:805-811.
35. Strain E.C., Stitzer M.L., Liebson I.A., Bigelow G.E. Buprenorphine versus methadone in the treatment of opioid dependence: Self-reports, urinalysis, and addiction severity index. Journal of Clinical Psychopharmacology 1996, 16:58-67.
36. Weinstock J., Alessi S.M., Petry N.M. Regardless of psychiatric severity the addition of contingency management to standard treatment improves retention and drug use outcomes. Drug and Alcohol Dependence 2007, 87:288-296.
37. Willett J.B., Singer J.D. Investigating onset, cessation, relapse, and recovery: Why you should, and how you can, use discrete-time survival analysis to examine event occurrence. Journal of Consulting and Clinical Psychology 1993, 61:952-965.
38. Williams J.W., Gibbon M., First M.B., Spitzer R.L., Davies M., Bors J., et al. The structured clinical interview for DSM-III-R (SCID) II: Multisite test-retest reliability. Archives of General Psychiatry 1992, 49:630-636.